A citation-based method for searching scientific literature

Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2022
Times Cited: 1076







List of co-cited articles
158 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
19

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

STROBE Reporting Guidelines for Observational Studies.
Amir A Ghaferi, Todd A Schwartz, Timothy M Pawlik. JAMA Surg 2021
65
7

Endometrial cancer.
Philippe Morice, Alexandra Leary, Carien Creutzberg, Nadeem Abu-Rustum, Emile Darai. Lancet 2016
839
5

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, Meher Ben Abdelghani, Alice C Wei, Jean-Luc Raoul, Laurence Choné, Eric Francois, Pascal Artru, James J Biagi,[...]. N Engl J Med 2018
5

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
5

Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Peter Bailey, Amber L Johns, David Miller, Katia Nones, Kelly Quek,[...]. Nature 2015
4


Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Marie-Claude Gingras, David K Miller, Angelika N Christ, Tim J C Bruxner, Michael C Quinn,[...]. Nature 2016
4

Pancreatic cancer.
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Lancet 2020
574
4

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
4

Colorectal cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, Stacey A Fedewa, Lynn F Butterly, Joseph C Anderson, Andrea Cercek, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2020
3

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
3



Non-small cell lung cancer: current treatment and future advances.
Cecilia Zappa, Shaker A Mousa. Transl Lung Cancer Res 2016
758
3

Contemporary management of endometrial cancer.
Jason D Wright, Nicanor I Barrena Medel, Jalid Sehouli, Keiichi Fujiwara, Thomas J Herzog. Lancet 2012
201
3


Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
3

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
897
3

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer.
Louis Buscail, Barbara Bournet, Pierre Cordelier. Nat Rev Gastroenterol Hepatol 2020
189
3

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
3

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
3

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Patrick M Forde, Jamie E Chaft, Kellie N Smith, Valsamo Anagnostou, Tricia R Cottrell, Matthew D Hellmann, Marianna Zahurak, Stephen C Yang, David R Jones, Stephen Broderick,[...]. N Engl J Med 2018
919
3


Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.
Eric A Collisson, Anguraj Sadanandam, Peter Olson, William J Gibb, Morgan Truitt, Shenda Gu, Janine Cooc, Jennifer Weinkle, Grace E Kim, Lakshmi Jakkula,[...]. Nat Med 2011
971
3

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
Richard A Moffitt, Raoud Marayati, Elizabeth L Flate, Keith E Volmar, S Gabriela Herrera Loeza, Katherine A Hoadley, Naim U Rashid, Lindsay A Williams, Samuel C Eaton, Alexander H Chung,[...]. Nat Genet 2015
907
3

Therapeutic developments in pancreatic cancer: current and future perspectives.
John P Neoptolemos, Jörg Kleeff, Patrick Michl, Eithne Costello, William Greenhalf, Daniel H Palmer. Nat Rev Gastroenterol Hepatol 2018
464
3

Early detection of pancreatic cancer.
Stephen P Pereira, Lucy Oldfield, Alexander Ney, Phil A Hart, Margaret G Keane, Stephen J Pandol, Debiao Li, William Greenhalf, Christie Y Jeon, Eugene J Koay,[...]. Lancet Gastroenterol Hepatol 2020
120
3


Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
Harry J de Koning, Carlijn M van der Aalst, Pim A de Jong, Ernst T Scholten, Kristiaan Nackaerts, Marjolein A Heuvelmans, Jan-Willem J Lammers, Carla Weenink, Uraujh Yousaf-Khan, Nanda Horeweg,[...]. N Engl J Med 2020
895
3

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Veeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A Mynderse, Markku H Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G Hindley,[...]. N Engl J Med 2018
2

Structural racism and health inequities in the USA: evidence and interventions.
Zinzi D Bailey, Nancy Krieger, Madina Agénor, Jasmine Graves, Natalia Linos, Mary T Bassett. Lancet 2017
2

HPV Vaccination and the Risk of Invasive Cervical Cancer.
Jiayao Lei, Alexander Ploner, K Miriam Elfström, Jiangrong Wang, Adam Roth, Fang Fang, Karin Sundström, Joakim Dillner, Pär Sparén. N Engl J Med 2020
305
2

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.
Jim C Hu, Paul Nguyen, Jialin Mao, Joshua Halpern, Jonathan Shoag, Jason D Wright, Art Sedrakyan. JAMA Oncol 2017
91
2

Reconsidering the Trade-offs of Prostate Cancer Screening.
Jonathan E Shoag, Yaw A Nyame, Roman Gulati, Ruth Etzioni, Jim C Hu. N Engl J Med 2020
29
6

Body Fatness and Cancer--Viewpoint of the IARC Working Group.
Béatrice Lauby-Secretan, Chiara Scoccianti, Dana Loomis, Yann Grosse, Franca Bianchini, Kurt Straif. N Engl J Med 2016
2

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
2

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
2

Cancer statistics for the year 2020: An overview.
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion Piñeros, Ariana Znaor, Freddie Bray. Int J Cancer 2021
585
2

Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.
Hongmei Zeng, Wanqing Chen, Rongshou Zheng, Siwei Zhang, John S Ji, Xiaonong Zou, Changfa Xia, Kexin Sun, Zhixun Yang, He Li,[...]. Lancet Glob Health 2018
486
2

EMT in cancer.
Thomas Brabletz, Raghu Kalluri, M Angela Nieto, Robert A Weinberg. Nat Rev Cancer 2018
972
2

Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
Wan Liu, Wenjing Wang, Xinran Wang, Cong Xu, Ning Zhang, Wen Di. Cancer Lett 2020
45
4

Chemokine CCL20 promotes the paclitaxel resistance of CD44+CD117+ cells via the Notch1 signaling pathway in ovarian cancer.
Min Chen, Juan Su, Chunmei Feng, Ying Liu, Li Zhao, Yongjie Tian. Mol Med Rep 2021
6
33

The CCL20-CCR6 Axis in Cancer Progression.
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami. Int J Mol Sci 2020
46
4

Cancer stem cells in progression of colorectal cancer.
Yujuan Zhou, Longzheng Xia, Heran Wang, Linda Oyang, Min Su, Qiang Liu, Jingguan Lin, Shiming Tan, Yutong Tian, Qianjin Liao,[...]. Oncotarget 2017
116
2

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
Juan Sandoval, Jesus Mendez-Gonzalez, Ernest Nadal, Guoan Chen, F Javier Carmona, Sergi Sayols, Sebastian Moran, Holger Heyn, Miguel Vizoso, Antonio Gomez,[...]. J Clin Oncol 2013
194
2

The fundamental role of epigenetic events in cancer.
Peter A Jones, Stephen B Baylin. Nat Rev Genet 2002
2

Cancer nanomedicine: progress, challenges and opportunities.
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
2

Clodronate.
Eugene McCloskey, Alexander H Paterson, Trevor Powles, John A Kanis. Bone 2021
7
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.